Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

NIH Strategic Plan for Research on FMR1-Associated Conditions

Image
Cover of NIH Strategic Plan for Research on FMR1-Associated Conditions.

This research plan describes current research on conditions linked to the FMR1 gene, including Fragile X syndrome, Fragile X-Associated Tremor and Ataxia Syndrome, and Fragile X-Associated Primary Ovarian Insufficiency and outlines future research areas and directions for NIH. 


This 44-page plan identifies priorities for NIH research activities on three conditions known to be associated with the FMR1 gene: Fragile X syndrome, Fragile X-associated Tremor and Ataxia Syndrome, and Fragile X-associated Primary Ovarian Insufficiency. It also describes research directions on the FMR1 gene itself, mutations that affect the gene’s function, and the role of the FMR1 protein in the development and progression of these conditions. It was developed over several years and incorporates input from scientists, healthcare providers, and support organizations with an interest in FMR1-related conditions, as well as families and individuals affected by the conditions.


Preferred Citation:
Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS. (2019). NIH Strategic Plan for Research on FMR1-Associated Conditions  (19-HD-8108). Washington, DC: U.S. Government Printing Office.
Date Published
Pages
44